Characteristic | Baseline (all) N = 30 | NH-1 N = 20 | NH-2 N = 10 | 3 months post (all) N = 30 | NH-1 N = 20 | NH-2 N = 10 |
---|---|---|---|---|---|---|
Age | 81.2 ± 14.5 | 77.3 ± 16.1 | 89.2 ± 5.4 | N/A | N/A | N/A |
Gender (% female) | 21 (70.0) | 15 (71.4) | 6 (60.0) | N/A | N/A | N/A |
Length of stay (months) | 30.4 (24.7) | 34.0 (24.1) | 23.1 (25.4) | N/A | N/A | N/A |
Cognitive Performance Scale | ||||||
0 (intact) | 3 (10.0) | 2 (10.0) | 1 (10.0) | 2 (6.7) | 2 (10.0) | 0 (0.0) |
≥ 1 (impaired) | 27 (90.0) | 18 (90.0) | 9 (90.0) | 28 (93.3) | 18 (90.0) | 10 (100.0) |
Activities of Daily Living (short form—ON site only) | ||||||
0 (independence) | 5 (25.0) | 5 (25.0) | 4 (20.0) | 4 (20.0) | ||
≥ 1 (dependence) | 15 (75.0) | 15 (75.0) | 16 (80.0) | 16 (80.0) | ||
Activities of Daily Living (self-performance hierarchy—Alberta site only) | ||||||
0 (independence) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | ||
≥ 1 (dependence) | 10 (100.0) | 10 (100.0) | 10 (100.0) | 10 (100.0) | ||
Depression Rating Scale | ||||||
0–2 (no disorders) | 8 (28.6) | 5 (25.0) | 5 (50.0) | 11 (36.7) | 5 (25.0) | 6 (60.0) |
≥ 3 (disorder) | 20 (71.4) | 15 (75.0) | 5 (50.0) | 19 (63.3) | 15 (75.0) | 4 (40.0) |
Changes in Health, End-Stage Disease, Signs, Symptoms Scale | ||||||
0 (not unstable) | 13 (43.3) | 9 (45.0) | 4 (40.0) | 12 (40.0) | 8 (40.0) | 4 (40.0) |
≥1 (unstable) | 17 (56.7) | 11 (55.0) | 6 (60.0) | 18 (60.0) | 12 (60.0) | 6 (60.0) |
Pain Scale | ||||||
0–1 (less than daily pain) | 25 (83.3) | 16 (80.0) | 9 (90.0) | 27 (90.0) | 17 (60.0) | 10 (100.0) |
≥ 2 (daily pain) | 5 (16.7) | 4 (20.0) | 1 (10.0) | 3 (10.0) | 3 (15.0) | 0 (0.0) |